Becton Dickinson and Co
NYSE:BDX

  • LAST PRICE
    230.9400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    229.0700/ 1
  • Ask / Lots
    233.0800/ 1
  • Open / Previous Close
    0.0000 / 230.9400
  • Day Range
    ---
  • 52 Week Range
    224.0000
    287.3200
  • Volume
    11

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
BDX
Becton Dickinson and Co
66.9B
49.2x
+11.04%
DXCM
Dexcom Inc
45.1B
75.5x
---
IDXX
IDEXX Laboratories Inc
40.4B
47.9x
+18.62%
MDT
Medtronic PLC
102.6B
28.4x
-4.17%
MTD
Mettler-Toledo International Inc
30.5B
39.4x
+12.39%
BAX
Baxter International Inc
17.3B
-439.7x
---
As of 2024-06-28

Company Information

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Contact Information

Headquarters
One Becton DriveFRANKLIN LAKES, NJ, United States 07417-1880
Phone
201-847-6800
Fax
---

Executives

Chairman of the Board, President, Chief Executive Officer
Thomas Polen
Chief Financial Officer, Executive Vice President
Christopher DelOrefice
Executive Vice President, President - Life Sciences Segment
David Hickey
Chief People Officer, Executive Vice President
Shana Neal
Executive Vice President, President, North America, Chief Marketing Officer
Antoine Ezell

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$66.9B
Revenue (TTM)
$19.7B
Shares Outstanding
289.0M
Dividend Yield
1.65%
Annual Dividend Rate
3.8000 USD
Ex-Dividend Date
06-10-24
Pay Date
06-28-24
Beta
0.43
EPS
$4.70
Book Value
$88.83
P/E Ratio
49.2x
Price/Sales (TTM)
3.4
Price/Cash Flow (TTM)
18.3x
Operating Margin
10.50%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.